Abbott Molecular, Inc.: Device Recall
Recall #Z-1749-2025 · 04/28/2025
Recall Details
- Recall Number
- Z-1749-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Abbott Molecular, Inc.
- Status
- Ongoing
- Date Initiated
- 04/28/2025
- Location
- Des Plaines, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 656 units
Reason for Recall
There were reports of an increase in reactive negative controls and false positive results.
Product Description
Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.
Distribution Pattern
Worldwide - US Nationwide distribution.
Other Recalls by Abbott Molecular, Inc.
- Class II: Risk 04/28/2025
- Class II: Risk 03/20/2025
- Class II: Risk 09/12/2024
- Class II: Risk 09/12/2024